BRIEF-GSK Starts Phase III Study Of Benlysta And Rituximab Combination For SLE
March 20, 2018 at 06:42 AM EDT
* GLAXOSMITHKLINE PLC - STARTS PHASE III STUDY OF BENLYSTA AND RITUXIMAB COMBINATION IN SYSTEMIC LUPUS ERYTHEMATOSUS
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|